Biogened S.A. (WSE:BGD)

Poland · Delayed Price · Currency is PLN

19.70

0.00 (0.00%)

Last updated: Oct 13, 2026, 11:16 AM CET

Market Cap	48.39M -17.9%
Revenue (ttm)	110.11M -2.3%
Net Income	5.13M -12.1%
EPS	2.09 -12.1%
Shares Out	2.46M
PE Ratio	9.54
Forward PE	n/a
Dividend	0.50 (2.54%)
Ex-Dividend Date	Sep 10, 2026

Volume	7
Open	19.70
Previous Close	19.70
Day's Range	19.70 - 19.70
52-Week Range	17.30 - 25.60
Beta	-0.01
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 16, 2026

About Biogened

Biogened S.A. produces and sells cosmetics and toiletries in Poland. The company offers dermo-cosmetics under the Dermedic brand, as well as thermal water. It also exports its products. The company was incorporated in 2007 and is headquartered in Lódz, Poland. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2007

Employees 186

Stock Exchange Warsaw Stock Exchange

Ticker Symbol BGD

Full Company Profile

Financial Performance

In 2025, Biogened's revenue was 113.11 million, an increase of 1.96% compared to the previous year's 110.93 million. Earnings were 4.94 million, a decrease of -15.11%.

Financial Statements